Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Average Target - GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price - GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

4536ed69.JxfLJcZoLFFUZHVN4myMwogsA94mLZtdqguIcNlfEyc.dlL7bYA6fRwGNxglsSnAuvsYNohFZ6sQ7EbARZgAcHBIc_lGtSQaYiwlHg~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +50%
+5.67%
+2.6%
+6.31%
+0.72%
+9.93%
-8.09%
+13.18%
-12.16%
+2.94%
Average +7.11%
Weighted average by Cap. +3.50%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
337.31PKR
Average target price
510.00PKR
Spread / Average Target
+51.20%
High Price Target
510.00PKR
Spread / Highest target
+51.20%
Low Price Target
510.00PKR
Spread / Lowest Target
+51.20%

Analyst Consensus Detail

Analyst consensus - GlaxoSmithKline Pakistan Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - GlaxoSmithKline Pakistan Limited
  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited